The product is described as a nasal spray that would repurpose a regular flu vaccine candidate, M2SR, by inserting gene sequences from the coronavirus strain that leads to COVID-19 into the influenza virus it already uses, according to a statement from the University of Wisconsin.
Office of Strategic Communication